PACO PEPTIDE
The first English-and-Spanish companion that actually understands GLP-1s — semaglutide, tirzepatide, retatrutide — without selling you anything and without prescribing.
If you already have the vial, this is for you.
Retatrutide. Cagrilintide. Survodutide. And the 20+ peptides people are using before your pharmacy knows how to spell them.
We read the studies, the preliminary publications, the conferences — in real time. We translate what matters: dosing, effects, risks, what honest doctors say when no one is recording them.
Bukowski isn't a doctor. He's an obsessive librarian with a subscription to every journal your doctor doesn't have time to open.
what asking him feels like
Why does semaglutide make me nauseous?¶Look. The nausea hits hard the first two weeks because your GLP-1 system is learning to slow gastric emptying. The STEP 1 trial reported around 44% experienced mild to moderate nausea during titration. Eat slow, stop when you're not hungry anymore, hydrate like you're in the desert. If it hits hard, OTC antiemetics are legit. Before changing doses, talk to your doctor.
what it does
Explains the molecule — how it works, where, how long, what the clinical trial behind it says.
Tells you what to expect — the adaptation curve, side effects, when it really starts working, when to stop worrying.
Gives you the regulatory landscape — 503A vs 503B, what changed in April, what COA to ask for, what's actually research-only and what isn't.
what it isn't
Not a doctor. For clinical questions, talk to yours.
Not a pharmacy. We don't sell anything — no peptides, no prescriptions, no vitamins.
Not going to push supplements at you every message. Bukowski has better things to do.
what you unlock
Unlimited Bukowski for GLP-1, peptide, side-effect, nutrition, and research questions.
Dose, weight, symptom, and sleep logging with a visual dashboard.
Export coach conversations as PDFs to bring context to your doctor.
Bilingual journal coverage translating studies, trials, and regulatory signals without selling you anything.
$79
per year
2 MONTHS FREE
Unlimited access to Bukowski. History saved. 2-day trial. Cancel in one click. No tricks, no "we'll give you a discount if you stay".
newsletter
Get the latest in peptide research